Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reteplase versus heparin for dysfunctional Permcath catheters in hemodialysis
IRCT20260226068952N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Apr 2026
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in dialysis catheter occlusion comparing Reteplase arm with Heparin control arm (2 arms). Primary endpoints: Number of effective catheter function days and Number of successful hemodialysis sessions after intervention. Started Apr 2026; status: completed.
02
Drugs
reteplaseheparin
03
Conditions
dialysis catheter occlusion
Beyond the preview
Go deeper on IRCT20260226068952N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260226068952N1.